Transcatheter superselective arterial embolization for the treatment of massive hemorrhage due to malignant gestational trophoblastic tumors
Hao SUN,Xiao-guang LI,Zheng-yu JIN,Ning YANG,Wei LIU,Jie PAN,Xiao-bo ZHANG,Hai-feng SHI,Kang ZHOU,Zhi-wei WANG
DOI: https://doi.org/10.3969/j.issn.1008-794X.2010.06.006
2010-01-01
Abstract:Objective: To evaluate the efficacy and safety of transcatheter superselective arterial embolization for controlling massive hemorrhage occurred in different parts of body due to malignant gestational trophoblastic tumors. Methods: During the period of January 1994-December 2009 in authors' hospital transcatheter superselective arterial embolization was performed in 80 patients for massive hemorrhage caused by malignant gestational trophoblastic tumors. Pathologically, the tumors included invasive mole (n = 18), choriocarcinoma (n = 59) and placentalsite trophoblastic tumor (n = 3). The bleeding sites included uterus (n = 58), vagina (n = 14), pelvic cavity (n = 2), bladder (n = 2), liver (n = 3) and rectum (n = 1). Based on the angiographic findings and the clinical judgment transeatheter arterial embolization with Gelfoam particles, coils and/or polyvinyl alcohol particles was carried out. All patients were followed up for 3 to 120 months (mean 30 months) after the procedure. Results: The superselective catheterization succeeded in all patients. Angiographic signs of hemorrhage were observed in 60 cases (75%). Hemorrhage was successfully controlled in 73 cases (91.3%). One patient (1.3%) died on the third day after procedure due to multiple organ failure. Six patients (7.5%) had repeated hemorrhage and had to receive operation. Side-effects included transient body pain (n = 30, 37.5%) and fever (n = 45, 56.3%). Conclusion: For the treatment of massive hemorrhage caused by malignant gestational trophoblastic tumors, transeatheter superselective arterial embolization is an effective and safe technique, which should be regarded as the therapy of first choice.